Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network (2017)
- Authors:
- Aliota, Matthew T
- Bassit, Leda
- Bradrick, Shelton S.
- Cox, Bryan
- Blanco, Mariano A. Garcia
- Gavegnano, Christina
- Friedrich, Thomas C.
- Golos, Thaddeus G
- Griffin, Diane E
- Haddow, Andrew D
- Kallás, Esper Georges
- Kitron, Uriel
- Lecuit, Diogo M
- Magnani, Diogo M
- Marrs, Caroline
- Mercer, Natalia
- McSweegan, Edward
- Ng, Lisa F. P
- O'connor, David H
- Osorio, Jorge E
- Ribeiro, Guilherme S
- Ricciardi, Michael
- Rossi, Shannan L
- Saade, George
- Schinazi, Raymond F
- Lerner, Geraldine O. Schott
- Shan, Chao
- Shi, Pei-Yong
- Watkins, David I
- Vasilakis, Nikos
- Weaver, Scott C
- Autor USP: KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1016/j.antiviral.2017.06.001
- Subjects: ZIKA VÍRUS; TRANSMISSÃO DE DOENÇAS; GRAVIDEZ; VACINAS VIRAIS; FETO; MALFORMAÇÕES
- Language: Inglês
- Imprenta:
- Source:
- Título: Antiviral research
- ISSN: 0166-3542
- Volume/Número/Paginação/Ano: v. 144, p. 223-226, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
ALIOTA, Matthew T et al. Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network. Antiviral research, v. 144, p. 223-226, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.antiviral.2017.06.001. Acesso em: 28 dez. 2025. -
APA
Aliota, M. T., Bassit, L., Bradrick, S. S., Cox, B., Blanco, M. A. G., Gavegnano, C., et al. (2017). Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network. Antiviral research, 144, 223-226. doi:10.1016/j.antiviral.2017.06.001 -
NLM
Aliota MT, Bassit L, Bradrick SS, Cox B, Blanco MAG, Gavegnano C, Friedrich TC, Golos TG, Griffin DE, Haddow AD, Kallás EG, Kitron U, Lecuit DM, Magnani DM, Marrs C, Mercer N, McSweegan E, Ng LFP, O'connor DH, Osorio JE, Ribeiro GS, Ricciardi M, Rossi SL, Saade G, Schinazi RF, Lerner GOS, Shan C, Shi P-Y, Watkins DI, Vasilakis N, Weaver SC. Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network [Internet]. Antiviral research. 2017 ; 144 223-226.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.antiviral.2017.06.001 -
Vancouver
Aliota MT, Bassit L, Bradrick SS, Cox B, Blanco MAG, Gavegnano C, Friedrich TC, Golos TG, Griffin DE, Haddow AD, Kallás EG, Kitron U, Lecuit DM, Magnani DM, Marrs C, Mercer N, McSweegan E, Ng LFP, O'connor DH, Osorio JE, Ribeiro GS, Ricciardi M, Rossi SL, Saade G, Schinazi RF, Lerner GOS, Shan C, Shi P-Y, Watkins DI, Vasilakis N, Weaver SC. Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network [Internet]. Antiviral research. 2017 ; 144 223-226.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.antiviral.2017.06.001 - Skewed distribution of natural killer cells in psoriasis skin lesions [Carta]
- Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study
- Abnormal phenotypic distribution of regulatory and effector T cells in octogenarian and nonagenarian women
- Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naive individual during the 2016 outbreak in Miami, FL
- MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection
- Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms
- Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic
- HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals
- Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study
- Análise de subtipos de linfócitos e aplicações clínicas
Informações sobre o DOI: 10.1016/j.antiviral.2017.06.001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
